Fatal hepatitis mediated by tumor necrosis factor TNFalpha requires caspase-8 and involves the BH3-only proteins Bid and Bim.

Immunity
Thomas KaufmannAndreas Strasser

Abstract

Apoptotic death of hepatocytes, a contributor to many chronic and acute liver diseases, can be a consequence of overactivation of the immune system and is often mediated by TNFalpha. Injection with lipopolysaccharide (LPS) plus the transcriptional inhibitor D(+)-galactosamine (GalN) or mitogenic T cell activation causes fatal hepatocyte apoptosis in mice, which is mediated by TNFalpha, but the effector mechanisms remain unclear. Our analysis of gene-targeted mice showed that caspase-8 is essential for hepatocyte killing in both settings. Loss of Bid, the proapoptotic BH3-only protein activated by caspase-8 and essential for Fas ligand-induced hepatocyte killing, resulted only in a minor reduction of liver damage. However, combined loss of Bid and another BH3-only protein, Bim, activated by c-Jun N-terminal kinase (JNK), protected mice from LPS+GalN-induced hepatitis. These observations identify caspase-8 and the BH3-only proteins Bid and Bim as potential therapeutic targets for treatment of inflammatory liver diseases.

References

Aug 28, 1998·Science·A Ashkenazi, V M Dixit
Dec 28, 1999·Proceedings of the National Academy of Sciences of the United States of America·D C HuangA Strasser
Aug 10, 2000·The American Journal of Pathology·L A O'ReillyA Strasser
Feb 20, 2003·Proceedings of the National Academy of Sciences of the United States of America·Kui Lei, Roger J Davis
Mar 26, 2003·Genes & Development·Leonardo SalmenaRazqallah Hakem
Jun 24, 2003·Neuron·Girish V PutchaEugene M Johnson
Jan 21, 2004·Proceedings of the National Academy of Sciences of the United States of America·Dan Chen, Qiang Zhou
Nov 15, 2006·Molecular and Cellular Biology·Xiaoyun ChenXiao-Ming Yin
Dec 22, 2007·Nature Reviews. Molecular Cell Biology·Richard J Youle, Andreas Strasser

❮ Previous
Next ❯

Citations

May 2, 2009·Cell Death and Differentiation·N AndinaH U Simon
Oct 1, 2011·Cell Death and Differentiation·T KaufmannP J Jost
Feb 16, 2013·Cell Death & Disease·F Marques-FernandezJ X Comella
Mar 4, 2011·Nature·William J KaiserEdward S Mocarski
Dec 21, 2013·Nature Reviews. Molecular Cell Biology·Peter E CzabotarJerry M Adams
Oct 21, 2010·Seminars in Liver Disease·Maria Eugenia Guicciardi, Gregory J Gores
Apr 27, 2011·Proceedings of the National Academy of Sciences of the United States of America·Owen M SiggsBruce Beutler
Oct 27, 2009·The Journal of Biological Chemistry·Eugene VarfolomeevDomagoj Vucic
Jun 3, 2010·The Journal of Biological Chemistry·Sayaka SuzukiYoshihiro Ishikawa
Aug 29, 2012·Antioxidants & Redox Signaling·Yoshiyuki MatsuoJunji Yodoi
Jul 29, 2010·Physiological Reviews·Harmeet MalhiGregory J Gores
Jul 16, 2010·The Journal of Clinical Investigation·Aditya MurthyRama Khokha
Oct 2, 2009·Journal of Cell Science·Grant Dewson, Ruth M Kluck
May 3, 2011·PloS One·Rebekka SchlatterIrmgard Merfort
Aug 25, 2012·World Journal of Gastroenterology : WJG·Hayato Nakagawa, Shin Maeda
Sep 16, 2014·Neural Regeneration Research·Yuan LiuShilei Gong
Jun 18, 2009·Seminars in Immunopathology·Nadia CorazzaChristoph Lauer
Feb 17, 2010·Cellular and Molecular Life Sciences : CMLS·Gabriela BrumattiPaul G Ekert
Jan 8, 2016·International Immunopharmacology·Kaiping WangYu Zhang
Mar 23, 2010·European Journal of Pharmacology·Seok-Joo KimSun-Mee Lee
Jul 25, 2009·Clinics in Liver Disease·Howard C MasuokaGregory J Gores
Aug 28, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Sven SchüngelArndt Vogel
Sep 30, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Sophie C Cazanave, Gregory J Gores
Sep 28, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Kathrin SchmichIrmgard Merfort
Mar 7, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Junfeng AnStefan Donath
Jun 20, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ji Hoon YuLothar Hennighausen
Apr 14, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hayato NakagawaShin Maeda
Sep 8, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Florian Baumgartner, Andreas Villunger
Jul 5, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Wei QiuJian Yu
Feb 18, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Philipp J Jost, Thomas Kaufmann
Dec 15, 2010·Journal of Hepatology·Shih-Yen WengHsin-Fang Yang-Yen
May 20, 2015·Immunopharmacology and Immunotoxicology·Mansheng LuoJimin Gao
Mar 10, 2015·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Muhammad Imran ArshadMichel Samson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Caspases in Metabolic Diseases

Caspases, the family of cysteine proteases are involved in programmed cell death, but their role in metabolic diseases, inflammation and immunity has been of interested. Discover the latest research on caspases in metabolic diseases here.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis